Peptides Derived from a Wild-Type Murine Proto-Oncogene c-erbB-2/HER2/neu Can Induce CTL and Tumor Suppression in Syngeneic Hosts

Journal of Immunology

Volumn 159, Issue 3, 1997, Pages 1336-1343

  Nagata, Yasuhiro ^a   Furugen, Reiko ^a   Hiasa, Atsunori ^a,c   Ikeda, Hiroaki ^c   Ohta, Nobuyoshi ^a   Furukawa, Keiko ^a   Nakamura, Hideo ^b   Furukawa, Koichi ^a   Kanematsu, Takashi ^a   Shiku, Hiroshi ^c  

^a NAGASAKI UNIVERSITY   (Japan)

^b MITSUBISHI CHEMICAL CORPORATION   (Japan)

^c MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GROWTH INHIBITOR; H2 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; PEPTIDE FRAGMENT;

ACTIVE IMMUNIZATION; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C3H MOUSE; CELL CULTURE; CELL STRAIN 3T3; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DBA MOUSE; DRUG EFFECT; FEMALE; FIBROSARCOMA; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOLECULAR CLONING; MOLECULAR GENETICS; MOUSE; SARCOMA;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; CLONING, MOLECULAR; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FIBROSARCOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH INHIBITORS; H-2 ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY, ACTIVE; LYMPHOCYTE ACTIVATION; MAST-CELL SARCOMA; METHYLCHOLANTHRENE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED DBA; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECEPTOR, ERBB-2; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031204947     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Boon, T., J.-C. Cerottini, B. van den Eynde, P. van der Bruggen, and A. van Pel. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12: 337.
2. Boon, T., and P. van der Bruggen. 1996. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183:752.
3. Brichard, V., A. Van Pel, T. Wölfel, C. Wölfel, E. De Plaen, B. Léthe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489.
4. Kawakami, Y., S. Eliyahu, C. H. Delgado, P. F. Robbins, L. Rivoltini, S. L. Topalian, T. Miki, and S. A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91:3515.
5. Bakker, A. B. H., M. W. J. Schreurs, A. J. de Boer, Y. Kawakami, S. A. Rosenberg, G. J. Adema, and C. G. Figdor. 1994. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179:1005.
6. Coussens, L., T. L. Yang-Feng, Y.-C. Liao. E. Chen, A. Gray, J. McGrath, P. H. Seeburg, T. A. Libermann, J. Schlessinger, U. Francke, A. Levinson, and A. Ullrich. 1985. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230:1132.
7. Semba, K., N. Kamata, K. Toyoshima, and T. Yamamoto. 1985. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc. Natl. Acad. Sci. USA 82:6497.
8. Ioannides, C. G., B. Fisk, D. Fan, W. E. Biddison, J. T. Wharton, and C. A. O'Brian. 1993. Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene. Cell. Immunol. 151: 225.
9. Yoshino, I., P. S. Goedegebuure, G. E. Peoples, A. S. Parikh, J. M. DiMaio, H. K. Lyerly, A. D. Gazdar, and T. J. Eberlein. 1994. HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer. Cancer Res. 54:3387.
10. Fisk, B., T. L. Blevins, J. T. Wharton, and C. G. Ioannides. 1995. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines. J. Exp. Med. 181:2109.
11. DeLeo, A. B., H. Shiku, T. Takahashi, M. John, and L. J. Old. 1977 Cell surface antigens of chemically induced sarcomas of the mouse I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcomas cells: description of a unique antigen on BALB/c Meth A sarcoma. J. Exp. Med. 146:720.
12. Van Pel, A., E. De Plaen, and T. Boon. 1985. Selection of highly transfectable variant from mouse mastocytoma P815. Somat. Cell Mol. Genet. 11:467.
13. Lattime, E. C., and O. Stutman. 1989. Tumor growth in vivo selects for resistance to tumor necrosis factor. J. Immunol. 143:4317.
14. Dialynas, D. P., Z. S. Quan, K. A. Wall, A. Pierres, J. Quintans, M. R. Loken, M. Pierres, and F. W. Fitch. 1983. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131:2445.
15. Nakayama, E., and A. Uenaka. 1985. Effect of in vivo administration of Lyt antibodies: Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejection. J. Exp. Med. 161:345.
16. Kubo, R. T., W. Born, J. W. Kappler, P. Marrack, and M. Pigeon. 1989. Characterization of a monoclonal antibody which detects all murine αβ T cell receptors. J. Immunol. 142:2736.
17. Itohara, S., N. Nakanishi, O. Kanagawa, R. Kubo, and S. Tonegawa. 1989. Monoclonal antibodies specific to native murine T-cell receptor γδ: analysis of γδ T cells during thymic ontogeny and in peripheral lymphoid organs. Proc. Natl. Acad. Sci. USA 86:5094.
18. Leo. O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
19. d antigens on the surface of these cells. Transplantation 34:113.
20. Kappler, J. W., B. Skidomore, J. White, and P. Marrack. 1981. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas: lack of independent antigen and H-2 recognition. J. Exp. Med. 153:1198.
21. Fendly, B. M., M. Winget, R. M. Hudziak, M. T. Lipari, M. A. Napier, and A. Ullrich. 1990. Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. Cancer Res. 50:1550.
22. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
23. Furukawa, K., K. Furukawa, and H. Shiku. 1991. Alternatively spliced mRNA of the pX region of human T lymphotropic virus type I proviral genome. FEBS Lett. 295:141.
24. Sabath, D. E., H. E. Broome, and M. B. Prystowsky. 1990. Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene 91:185.
25. Nakayama, E., H. Shiku, T. Takahashi, H. F. Oettgen, and L. J. Old. 1979. Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 76:3486.
26. Falk, K., O. Rötzschke, S. Stevanović, G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
27. Peace, D. J., J. W. Smith, W. Chen, S.-G. You, W. L. Cosand, J. Blake, and M. A. Cheever. 1994. Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide. J. Exp. Med. 179:473.
28. + cytotoxic T-cells. Cancer Res. 53:3257.
29. Chen, W., D. J. Peace, D. K. Rovira, S.-G. You, and M. A. Cheever. 1992. T-cell immunity to the joining region of p210 bcr-abl protein. Proc. Natl. Acad. Sci. USA 89:1468.
30. Slamon, D. J., W. Godolphin, L. A. Jones, J. A. Holt, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Stuart, J. Udove, A. Ullrich, and M. F. Press. 1989. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707.
31. Yokota, J., T. Yamamoto, K. Toyoshima, M. Terada, T. Sugimura, H. Battifora, and M. J. Cline. 1986. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet 1:765.
32. Di Fiore, P. P., J. H. Pierce, M. H. Kraus, O. Segatto, C. R. King, and S. A. Aaronson. 1987. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237:178.
33. Natali, P. G., M. R. Nicotra, A. Bigotti, I. Venturo, D. J. Slamon, B. M. Fendly, and A. Ullrich. 1990. Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues. Int. J. Cancer 45:457.